Related Experiment Video
Updated: Jun 3, 2026
11:22
The α-test: Rapid Cell-free CD4 Enumeration Using Whole Saliva
Published on: May 16, 2012
Pediatric oral HIV research in the developing world
V Yengopal1, A Bhayat, M Coogan
1Division of Oral Public Health, University of Witswatersrand, Johannesburg, South Africa. Veerasamy.yengopal@wits.ac.za
Advances in Dental Research
|March 29, 2011
Summary
This review covers oral lesions in HIV infection from 2003-2009. It examines their prevalence, predictive value, and role in monitoring treatment effectiveness and quality of life.
Area of Science:
- Oral medicine
- Infectious diseases
- Public health
Background:
- Oral lesions are common in individuals with Human Immunodeficiency Virus (HIV) infection.
- Understanding the relationship between oral health and HIV is crucial for patient management.
Purpose of the Study:
- To review the literature on oral lesions associated with HIV infection from 2003 to 2009.
- To explore oral lesions as predictors of HIV status and markers of treatment efficacy.
- To assess the impact on quality of life, caries risk, and management strategies.
Main Methods:
- Literature review of scientific articles published between 2003 and April 2009.
- Focus on studies concerning oral lesions, HIV infection, and highly active antiretroviral therapy (HAART).
Main Results:
- Oral lesions are significant indicators of HIV infection prevalence.
- Certain oral lesions can predict HIV status and serve as markers for HAART efficacy.
- Management of oral lesions impacts patient quality of life and caries risk.
Conclusions:
- Oral health surveillance is vital in HIV management.
- Further research is needed on epidemiologic tests for clinical significance of oral lesions.
- Oral lesions provide valuable insights into HIV disease progression and treatment response.
Related Concept Videos
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...